Correlation Between Alpha Teknova and Transcode Therapeutics

Can any of the company-specific risk be diversified away by investing in both Alpha Teknova and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alpha Teknova and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alpha Teknova and Transcode Therapeutics, you can compare the effects of market volatilities on Alpha Teknova and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alpha Teknova with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alpha Teknova and Transcode Therapeutics.

Diversification Opportunities for Alpha Teknova and Transcode Therapeutics

-0.16

Correlation Coefficient

Alpha Teknova  Transcode Therapeutics

Good diversification

The 3 months correlation between Alpha and Transcode is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Alpha Teknova and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Alpha Teknova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alpha Teknova are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Alpha Teknova i.e., Alpha Teknova and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between Alpha Teknova and Transcode Therapeutics

Given the investment horizon of 90 days Alpha Teknova is expected to under-perform the Transcode Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Alpha Teknova is 1.83 times less risky than Transcode Therapeutics. The stock trades about -0.15 of its potential returns per unit of risk. The Transcode Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  981.00  in Transcode Therapeutics on May 8, 2025 and sell it today you would earn a total of  149.00  from holding Transcode Therapeutics or generate 15.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Alpha Teknova  vs.  Transcode Therapeutics

Alpha Teknova

Risk-Adjusted Performance

Weakest

Over the last 90 days Alpha Teknova has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in September 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Transcode Therapeutics

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Transcode Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alpha Teknova and Transcode Therapeutics

The main advantage of trading using opposite Alpha Teknova and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alpha Teknova position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.

The idea behind Alpha Teknova and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.